Filing Flows

Filing Flows › Procept BioRobotics (PRCT) › Next earnings date

Procept BioRobotics (PRCT) earnings: missed the estimate

Procept BioRobotics (PRCT) reported on Nov 4, 2026 and missed the EPS estimate: −$0.46 against −$0.39 (-18.1%). Revenue was $98.3M for Q3 2026, +18% year over year. It beat the EPS estimate in 40% of the quarters on record.

Last result−18.1% vs estimate
Beat rate40%

The last report

Procept BioRobotics reported revenue of $98.3M for the third quarter 2026 (+18% Y/Y), net loss $26.5M. How it makes money → · Every quarter →

Procept BioRobotics: EPS against the estimate, last 5 reportsProcept BioRobotics: EPS against the estimate, last 5 reportsEstimateReported−$0.42−$0.38Nov 25−$0.32−$0.53Feb 26−$0.56−$0.56Apr 26−$0.45−$0.47Aug 26−$0.39−$0.46Nov 26
Latest (Nov 26): Estimate −$0.39, Reported −$0.46.
PRCT: the stock's move on each reportPRCT: the stock's move on each reportAug 4, 2026+5.2%Apr 29, 2026+4.4%Feb 25, 2026-13.3%Nov 4, 2025-8.4%

Procept BioRobotics' latest quarter

Procept BioRobotics, Q3 2026: revenue $98.3M (+18% year over year), operating margin -27.9%, net loss $26.5M, operating cash flow −$9.0M. The chart follows the revenue to costs, profit and cash.

Questions

Did Procept BioRobotics beat earnings?

Procept BioRobotics (PRCT) reported on Nov 4, 2026 and missed the EPS estimate: −$0.46 against −$0.39 (-18.1%).

When does PRCT report earnings?

The next date is not set yet.

Does Procept BioRobotics usually beat earnings?

It beat the consensus EPS estimate in 40% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.